NEVRO CORP Human Resources Contracts & Agreements
39 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Change of Control Agreements (19)
- Compensation Agreements (5)
- Employment Agreements (3)
- Separation Agreements (5)
- Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on November 1, 2023)
- Separation Agreement, dated June 30, 2023, by and between Niamh Pellegrini and the Company (Filed With SEC on August 1, 2023)
- Change in Control Severance Agreement, dated June 20, 2023, between Greg Siller and the Company (Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Kashif Rashid and the Company (Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Niamh Pellegrini and the Company (Filed With SEC on August 1, 2023)
- Amendment No. 1 to Change in Control Severance Agreement, dated as of April 19, 2023, by and between Rod MacLeod and the Company (Filed With SEC on August 1, 2023)
- Employment Agreement by and between Kevin Thornal and the Company, effective as of April 24, 2023 (Filed With SEC on August 1, 2023)
- Amended and Restated Employment Agreement, by and between D. Keith Grossman and the Company, effective as of April 24, 2023 (Filed With SEC on August 1, 2023)
- Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 23, 2022)
- Change in Control Severance Agreement, dated as of June 15, 2020, by and between Roderick H. MacLeod and the Company (Filed With SEC on August 5, 2020)
- Second Amended and Restated Company Bonus Plan (Filed With SEC on August 5, 2020)
- Form of Performance Stock Award Agreement and Performance Stock Award Grant Notice under the 2014 Equity Incentive Award Plan (Filed With SEC on May 5, 2020)
- Transition and Separation Agreement, dated as of January 7, 2020, by and between the Company and Doug Alleavitch (Filed With SEC on February 25, 2020)
- Change in Control Severance Agreement, dated as of September 16, 2019, by and between Niamh Pellegrini and the Company (Filed With SEC on February 25, 2020)
- Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Patrick Schmitz and the Company (Filed With SEC on November 6, 2019)
- Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Kashif Rashid and the Company (Filed With SEC on November 6, 2019)
- Amended and Restated Change in Control Severance Agreement, effective July 22, 2019, by and between Doug Alleavitch and the Company (Filed With SEC on November 6, 2019)
- Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on August 8, 2019)
- Amended and Restated Change in Control Severance Agreement, effective June 5, 2019, by and between Andrew Galligan and the Company (Filed With SEC on August 8, 2019)
- Separation Agreement, dated March 18, 2019, by and between Rami Elghandour and the Company (Filed With SEC on May 9, 2019)
- Employment Agreement by and between D. Keith Grossman and the Company, effective as of March 19, 2019 (Filed With SEC on May 9, 2019)
- Nevro Corp. Non-Employee Director Compensation Program, as amended (Filed With SEC on February 21, 2019)
- Transition and Separation Agreement by and between the Company and James Alecxih dated July 27, 2018 (Filed With SEC on August 2, 2018)
- Non-Employee Director Compensation Program, as amended (Filed With SEC on May 7, 2018)
- Amended and Restated Company Bonus Plan (Filed With SEC on May 7, 2018)
- Amended and Restated Change in Control Severance Agreement, dated as of December 18, 2017, by and between Kashif Rashid and the Company (Filed With SEC on February 22, 2018)
- Amended and Restated Change in Control Severance Agreement, dated as of December 14, 2017, by and between James Alecxih and the Company (Filed With SEC on February 22, 2018)
- Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Christofer Christoforou and the Company (Filed With SEC on February 22, 2018)
- Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Patrick Schmitz and the Company (Filed With SEC on February 22, 2018)
- NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on November 7, 2016)
- NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 8, 2016)
- NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 8, 2016)
- NEVRO CORP. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 8, 2016)
- GENERAL RELEASE AND SEPARATION AND TRANSITION AGREEMENT (Filed With SEC on August 8, 2016)
- NEVRO CORP. AMENDEDAND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 9, 2016)
- NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on October 10, 2014)
- NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE (Filed With SEC on October 10, 2014)
- NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 10, 2014)
- NEVRO CORP. 2014 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on October 10, 2014)